Benitec Biopharma (BNTC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist

10.8600
+1.0500+10.70%

Close Oct 11 16:00 ET

10.7700
-0.0900-0.83%

Post 17:13 ET

114.64MMarket Cap-1970P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Benitec Biopharma Inc: Under the Agreement, Co to Offer up to $75 Mln of Co's Common Stock
Reuters17:19 ET
Express News | Benitec Biopharma Inc: Co Entered Into Sales Agreement With Leerink Partners LLC
Reuters17:18 ET
Here's Why We're Not Too Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation
Simply Wall StOct 2 09:43 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
BenzingaOct 1 12:31 ET
Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc
Yahoo FinanceSep 30 21:03 ET
Benitec Biopharma Analyst Ratings
BenzingaSep 30 09:33 ET · Ratings

Comments

Trytosaveabit

Apr 18 06:35

News

$Benitec Biopharma (BNTC.US)$ Benitec Biopharma Inc: Bb-301 Has Been Granted Orphan Drug Designation by US FDA and EMA Committee for Orphan Medicinal Products (Comp)

GreenIsMyName

Apr 18 06:32

$Benitec Biopharma (BNTC.US)$ phase 1 :X

Trytosaveabit

Apr 18 06:31

Update

$Benitec Biopharma (BNTC.US)$ Benitec Biopharma Reports Positive Interim Clinical Trial Data for First Opmd Subject Treated With Bb-301 in Phase 1B/2a Study

Jaguar8

Apr 18 06:31

$Benitec Biopharma (BNTC.US)$
NEWS
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Positive interim clinical trial data for the first OPMD subject treated with BB-301 in a Phase 1b/2a study
Improvements in swallowing function demonstrated in multiple measures following BB-301 administration
No serious adverse events reported, with transient GERD resolved with common medications
Encouraging early clinical trial result...